Quantification of Immuno-status of patients after infection or vaccination
Chorus SARS-CoV-2 “Neutralizing” Ab
Quantitative determination of total antibodies IgG ,IgM and IgA
Standardized against the first WHO International Standard
Complete solution to support patient’s health vs SARS-CoV-2
Quick and reliable detection of viral antigen in
suspected Covid-19 patients
Chorus SARS-CoV-2 Antigen
Semi-Quantitative determination of antigen in nasopharyngeal swab
Complete panel for the identification of the
antibodies response
Chorus SARS-CoV-2 IgG, IgM, IgA and Screen Serum
Qualitative tests to screen the specific immunoglobulin levels during the different phase of the infection
Single-test devices
Easy and ready-to-use
No hidden costs
No waste of reagents
Coronavirus disease
QUALITATIVE TEST ON SERUM SAMPLE
Chorus SARS-CoV-2 IgAFor the qualitative determination of IgA antibodiesanti-SARS-CoV-2 virus. |
36 tests | 81402 |
Chorus SARS-CoV-2 IgGFor the qualitative determination of IgG antibodiesanti-SARS-CoV-2 virus. |
36 tests | 81400 |
Chorus SARS-CoV-2 IgMFor the qualitative determination of IgM antibodiesanti-SARS-CoV-2 virus. |
36 tests | 81401 |
Chorus SARS-CoV-2 Screen SerumFor the qualitative determination of total antibodiesanti-SARS-CoV-2 virus as an aid in the determination of the immune reaction to SARS-CoV-2. |
36 tests | 81406 |
SEMI - QUANTITATIVE TEST ON SWAB SAMPLE
Chorus SARS-CoV-2 AntigenFor the semi-quantitative determination of SARS-CoV-2 virus |
36 tests | 81410 |
QUANTITATIVE TEST ON SERUM SAMPLE
Chorus SARS-CoV-2 “NEUTRALIZING” AbFor the quantitative determination of total antibodies anti-S1 SARS-CoV-2 |
36 tests | 81408 |
Diesse Press Release
COVID-19: the alliance between Diesse and TLS produces the diagnostic kit used in clinical trials on monoclonal antibody therapy
09 March 2021
Diesse and AchilleS Vaccines working together for new monoclonal antibody based therapies
19 February 2021
DIESSE LAUNCHES THE SARS-CoV-2 “NEUTRALIZING” Ab, AN IMPORTANT TEST FOR MEASURING VACCINE EFFECTIVENESS
29 January 2021
Rassegna stampa
medicalexcellencetv - Covid: kit diagnostico impiegato nei trial clinici sulla terapia a base di anticorpi monoclonali, frutto dell’alleanza tra Diesse e TLS
09 March 2021
TGCOM ECONOMIA - COVID: DA ALLEANZA DIESSE-TLS IMPIEGO KIT DIAGNOSTICO NEI TRIAL CLINICI
09 March 2021
Centritalianews - Siena: frutto dell’alleanza tra Diesse e TLS il kit diagnostico impiegato nei trial clinici sulla terapia a base di anticorpi monoclonali. Sviluppato da Diesse, partendo dall’esperienza sugli anticorpi monoclonali del MAD Lab di Fondazione TLS, il kit supporterà la diagnosi e il monitoraggio durante le fasi cliniche appena avviate
09 March 2021
ABOUTPHARMA - Test per gli anticorpi monoclonali: partnership tra Diesse e AchilleS Vaccines
19 February 2021
toscana24.ilsole24ore - Alleanza senese per i test sugli anticorpi monoclonali
19 February 2021
AgenziaImpress - Coronavirus. Da Siena il test Sars-Cov-2 “Neutralizing” che misura l’efficacia dei vaccini
29 January 2021
i-TALICOM - DIESSE lancia il test SARS-CoV-2 “NEUTRALIZING” Ab, utile per misurare l’efficacia dei vaccini
29 January 2021
i-TALICOM: DIESSE annucnia il primo kit per la ricerca di anticorpi neutralizzanti Sars – CoV-2
10 December 2020
TgCom24 - DIESSE: 1* KIT PER RICERCA ANTICORPI NEUTRALIZZANTI SARS-COV-2
10 December 2020
Agenziaimpress - Coronavirus. Da Diagnostica Senese un nuovo kit per la ricerca dell’antigene Sars-Cov 2
19 November 2020
toscana24.ilsole24ore - Diesse 'abbandona' il tampone su saliva
19 November 2020
Diesse annuncia la nuova configurazione del sistema per immunodosaggi «Chorus Trio»
03 November 2020
La Nazione - La Ves negli animali C’è un nuovo misuratore
16 October 2020
Finanza.tgcom24.mediaset - DIESSE: NUOVO STRUMENTO MISURAZIONE VES DEDICATO AGLI ANIMALI
15 October 2020
Coronavirus. Da Siena un nuovo test per lo screening immunitario. Il kit di Diesse promette risposta in un’ora
09 October 2020
Corriere Quotidiano - Coronavirus: nuovo test screening immunitario in un'ora
08 October 2020
Video, dirette streaming e interviste
Diesse Diagnostica
Diesse Diagnostica Senese SpA is an Italian company with integrated and entirely in-house production of in vitro diagnostic systems. Its headquarters are in Siena. Since its foundation in 1980, the company has developed, produced and marketed innovative diagnostic systems primarily in the field of immunodiagnostics and automatic measurement of erythrocyte sedimentation rate (ESR). The company has a global presence in over 100 countries, three production sites and a research centre where the design and implementation of tests and new automated diagnostic detection tools meet Italian design and cutting-edge technology, making Diesse synonymous with "Diagnostics Evolution".
Social Media